Clinical Trial Update: Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on the safety and efficacy evaluation of the investigational agent BMS-986504 in unresectable malignant peripheral nerve shea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peripheral Nerve Sheath Tumor

Drugs mentioned

• BMS-986504

Snippet

Sponsor: Ankit Mangla, MD | Conditions: Malignant Peripheral Nerve Sheath Tumors, MPNST | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING